Frontiers in Cardiovascular Medicine

JULY 8, 2024

BackgroundHuman pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) show tremendous promise for cardiac regeneration following myocardial infarction (MI), but their transplantation gives rise to transient ventricular tachycardia (VT) in large-animal MI models, representing a major hurdle to translation.

Pacemaker 52

Pacemaker CMS Arrhythmia Transplant 52

Journal of Cardiovascular Electrophysiology

JANUARY 15, 2024

Abstract Introduction Atrial fibrillation and atrial flutter originating from the donor s heart is a commonly reported complication post heart transplant. Case A 47-year-old male presented with atrial tachycardia 6 months post heart transplant. This arrhythmia was successfully terminated with radiofrequency ablation.

Atrial Fibrillation 40

Atrial Fibrillation Heart Transplant Atrial Flutter Transplant 40

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 12, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. The transplant-free survival rates at 3, 5, and 8 years after CRT implantation were 85%, 79%, and 73%.CONCLUSIONS:In Although cardiac resynchronization therapy (CRT) is an established treatment option, the effect of CRT in this population is still not well defined.

Congenital Heart Disease 40

Congenital Heart Disease Outcomes Electrophysiology Congenital 40

Circulation

FEBRUARY 15, 2024

Lethally irradiated mice were transplanted with hematopoietic-specific loss ofTet2, hematopoietic-specific loss ofTet2andNlrp3, or wild-type control and fed a Western diet, compounded with or without NLRP3 (NLR [NACHT, LRR {leucine rich repeat}] family pyrin domain containing protein 3) inhibitor, NP3-361, for 6 to 9 weeks.

Atrial Fibrillation 45

Atrial Fibrillation Diet Myocardial Infarction Cardiovascular Disease 45

Journal of Cardiovascular Electrophysiology

MARCH 10, 2024

Two cases were postbilateral orthotopic lung transplant, without appropriate femoral or jugular access due to recent ECMO cannulation and jugular central venous catheters. Abstract Introduction Transsubclavian venous implantation of the Aveir leadless cardiac pacemaker (LCP) has not been previously reported.

Transplant 40

Transplant Pacemaker 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 17, 2023

After excluding patients with congenital or rheumatic heart disease, heart transplant recipients, or those without baseline echocardiogram, a total of 130 patients were included in the analysis. Echocardiographic data were analyzed at baseline before ablation, and at early follow-up within 1-year postablation.

Atrial Flutter 40

Atrial Flutter Ablation Heart Transplant Tricuspid 40

DAIC

MARCH 8, 2024

Cardiac transplantation, the only option for many patients, is severely restricted by the limited availability of donor hearts. The research is funded by a four-year, $7.8 Patients with heart failure often experience reduced mobility, quality of life and ability to work; the disease also represents a significant public health care burden.

Blood Clot 98

Blood Clot Heart Failure Quality of Life Innovation 98